Small Molecule Inhibitors Target the Tissue Transglutaminase and Fibronectin Interaction
Open Access
- 20 February 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (2) , e89285
Abstract
Tissue transglutaminase (TG2) mediates protein crosslinking through generation of ε−(γ-glutamyl) lysine isopeptide bonds and promotes cell adhesion through interaction with fibronectin (FN) and integrins. Cell adhesion to the peritoneal matrix regulated by TG2 facilitates ovarian cancer dissemination. Therefore, disruption of the TG2-FN complex by small molecules may inhibit cell adhesion and metastasis. A novel high throughput screening (HTS) assay based on AlphaLISA™ technology was developed to measure the formation of a complex between His-TG2 and the biotinylated FN fragment that binds TG2 and to discover small molecules that inhibit this protein-protein interaction. Several hits were identified from 10,000 compounds screened. The top candidates selected based on >70% inhibition of the TG2/FN complex formation were confirmed by using ELISA and bioassays measuring cell adhesion, migration, invasion, and proliferation. In conclusion, the AlphaLISA bead format assay measuring the TG2-FN interaction is robust and suitable for HTS of small molecules. One compound identified from the screen (TG53) potently inhibited ovarian cancer cell adhesion to FN, cell migration, and invasion and could be further developed as a potential inhibitor for ovarian cancer dissemination.Keywords
This publication has 33 references indexed in Scilit:
- Targeting Ovarian Tumor Cell Adhesion Mediated by Tissue TransglutaminaseMolecular Cancer Therapeutics, 2011
- Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial CellsPLOS ONE, 2010
- Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue TransglutaminaseCancer Research, 2009
- Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP-response Element-binding Protein ActivityJournal of Biological Chemistry, 2009
- Transglutaminase 2 Undergoes a Large Conformational Change upon ActivationPLOS Biology, 2007
- Enhanced Peritoneal Ovarian Tumor Dissemination by Tissue TransglutaminaseCancer Research, 2007
- Overexpression of Tissue Transglutaminase Leads to Constitutive Activation of Nuclear Factor-κB in Cancer Cells: Delineation of a Novel PathwayCancer Research, 2006
- Transglutaminase-mediated oligomerization of the fibrin(ogen) αC domains promotes integrin-dependent cell adhesion and signalingBlood, 2005
- Cell-Surface-Associated Tissue Transglutaminase Is a Target of MMP-2 ProteolysisBiochemistry, 2004
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999